REVOFIL™ FINE

REVOFIL FINE is a soft-touch dermal filler designed for the correction of superficial wrinkles, fine lines, and light dermal imperfections. It is part of the REVOFIL product line developed by Caregen, formulated to provide subtle volume enhancement with long-lasting and natural-looking results. Utilizing a unique combination of cross-linked hyaluronic acid (HA) and biomimetic peptides, REVOFIL FINE ensures enhanced durability and improved skin elasticity.

The filler exhibits high viscoelasticity and resistance to enzymatic degradation, leading to a longer-lasting aesthetic effect—often up to 10 months. Clinical studies show a 99% patient satisfaction rate, with no allergic responses observed in treated individuals. REVOFIL FINE is ideal for delicate areas such as tear troughs, upper eyelids, and temporal regions, where precision and softness are crucial.

• HA concentration: 23 mg/mL
  
• Needle size: 30G 1/2 inch
  
• Injection depth: Superficial dermis
  
• Duration: Approximately 10 months
• Recommended areas: Tear troughs, fine lines, upper cheeks, temples, upper eyelids, and hands

REVOFIL FINE is administered via intradermal injection using a fine 30G needle to target the superficial dermis layer. Its soft texture allows for controlled application, making it ideal for precise contouring in sensitive or thin-skinned areas.

• Injection depth: Superficial dermis
  
• Needle: 30G 1/2 inch
  
• Recommended areas: Tear troughs, temporal region, upper cheeks, hands, and upper eyelids
  
• Volume per syringe: 1 mL (pre-filled)
  
• Technique: Linear threading, micro-droplet, or serial puncture depending on area
• Touch-up interval: As needed, typically around 10 months

REVOFIL FINE is indicated for patients seeking subtle rejuvenation of fine lines, superficial wrinkles, and minor volume deficiencies. It is well-suited for early aging signs and is often used for tear trough correction, periorbital rejuvenation, and hand revitalization.

However, it is contraindicated in individuals with:

• Known hypersensitivity to hyaluronic acid
  
• Active skin infections or inflammation at the injection site
  
• Autoimmune disorders or coagulation disorders
  
• Pregnancy or breastfeeding
  

Potential side effects may include:

• Mild erythema, edema, or bruising at the injection site
  
• Tenderness or localized itching
  
• Rarely, nodules or hypersensitivity reactions
  
• Indications:
  
  • Superficial wrinkle correction
    
  • Fine line smoothing
    
  • Periorbital and hand rejuvenation
    
• Contraindications:
  
  • Allergy to HA or peptides
    
  • Local skin disorders
    
  • Systemic immune-related conditions

REVOFIL FINE is formulated with cross-linked hyaluronic acid (HA) and CG-Boostrin, a patented biomimetic peptide. This peptide-enhanced formulation increases the product’s stability, longevity, and regenerative potential.

• Hyaluronic acid concentration: 23 mg/mL
  
• Peptides: CG-Boostrin (a biomimetic peptide)
  
• Cross-linking technology: Uses a peptide-mediated disulfide bond for enhanced resistance to enzymatic degradation
  
• Additional benefits:
  
  • Inhibits hyaluronidase activity by up to 90%
    
  • Stimulates collagen synthesis by 81%
    
  • Increases endogenous HA by 45%
    
  • Offers anti-oxidative and UV protection benefits

Each unit of REVOFIL FINE is carefully packaged to ensure sterility and precise application. The product comes ready for use, requiring no reconstitution.

• Package contents:
  
  • 1 x 1 mL pre-filled syringe of REVOFIL FINE
    
  • 1 sterile 30G 1/2 inch needle
    
  • Patient tracking label
    
  • Instructional leaflet
    
• Packaging type: Sterile blister pack
  
• Storage format: Individually boxed

REVOFIL FINE has shown a very favorable safety profile in clinical studies. Out of 172 patients treated with REVOFIL products, no allergic reactions were observed, and 99% reported satisfaction with their results.

While side effects are generally mild and transient, some patients may experience:

• Redness, swelling, or bruising at the injection site
  
• Tenderness, itching, or pain
  
• In rare cases: lumps, discoloration, or hypersensitivity
  
• Common side effects:
  
  • Localized erythema or swelling
    
  • Minor pain or itching
    
• Rare side effects:
  
  • Granulomas
    
  • Infection
    
  • Delayed inflammatory response

To preserve its sterility and effectiveness, REVOFIL FINE must be stored under controlled conditions. The packaging is designed to protect the product from environmental exposure.

• Storage temperature: Between 2°C and 25°C
  
• Keep away from: Direct sunlight and heat sources
  
• Do not freeze
  
• Shelf life: Refer to the expiration date on the outer box
  
• Packaging: Sterile, sealed blister pack in individual carton
  

Always inspect the product for damage or expiration prior to use.